A randomized, double-blind, dose ranging clinical trial of intravenous FDY-5301 in acute STEMI patients undergoing primary PCI by Adlam, D, Zarebinski, M, Uren, NG, Ptaszynski, P, Oldroyd, KG, Munir, S, Zaman, A, Contractor, H, Kiss, RG, Édes, I, Szachniewicz, J, Nagy, GG, Garcia, MJ, Tomcsanyi, J, Irving, J, Sharp, ASP, Musialek, P, Lupkovics, G, Shirodaria, C, Selvanayagam, JB, Quinn, P, Ng, L, Roth, M, Insko, MA, Haber, B, Hill, S, Siegel, L, Tulloch, S, Channon, KM